Harvard Apparatus Regenerative Technology, Inc. (HRGN) › Capital ExpendituresHarvard Apparatus Regenerative Technology, Inc. (HRGN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $310.0K2013: $295.0K2014: $1.16M2015: $176.0K2016: $302.0K2017: $136.0K2018: $131.0K2019: $129.0K2020: $7.0K2021: $02022: $5.0K2023: $11.0K2024: $0$02012Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0-100.0%2023$11.0K+120.0%2022$5.0K—2021$0-100.0%2020$7.0K-94.6%2019$129.0K-1.5%2018$131.0K-3.7%2017$136.0K-55.0%2016$302.0K+71.6%2015$176.0K-84.9%2014$1.16M+294.6%2013$295.0K-4.8%2012$310.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share